180 likes | 272 Views
NeTT : Network of Translational Technologies. Mark W. Geraci, MD Associate Director, CCTSI Professor of Medicine. Specific Aims (or Objectives) CCTSI 2.0.
E N D
NeTT: Network of Translational Technologies Mark W. Geraci, MD Associate Director, CCTSI Professor of Medicine
Specific Aims (or Objectives)CCTSI 2.0 SA 5) Strengthen our integrated Network of Translational Technologies (NeTT) and laboratories that provide state-of-the-science services for comprehensive clinical and translational research. • We will implement a Core Laboratories Tracking & Management System to centralize tracking of the broad range of translational technology resources available to CCTSI members. A major focus is to accurately track utilization to improve cost-efficiencies and prioritization of resource allocation.
Approach - Innovation • Although rodent models serve an important purpose in moving studies of disease and therapy forward, there is much to be realized by capitalizing on availability of naturally occurring disease in outbred species with greater genetic, phenotypic, dietary, and morphologic similarities to humans.
Approach - Innovation • Drawing on the strengths of a world-class clinical faculty, this center will provide opportunities to clinically evaluate • drugs, • surgical interventions, • diagnostics and devices, • in naturally occurring, well- characterized diseases of companion and domestic animal species that recapitulate human diseases.
National CTSA Consortium Involvement • T1 Translational Key Function Committee • Mark Geraci, Member • Monthly calls • Best Practices for Methods Development • Novel and Innovative Technologies Demonstrations • Attempts at National Convergence • Databases of Service
Response to EAC Critiques • Not Reviewed last time • Some important points raised in the peer review
Response to EAC Critiques • Thanks !!
Response to EAC Critiques • We purposefully placed these functions with Dr. Kohrt, in alignment • CTRC Cores are (human) clinical-based and NeTT are research-oriented
Response to EAC Critiques • Due to broad inclusion, nearly all scientists are CCTSI-affiliated • OR….They become affiliated at the time of Core Use
Questions for EAC • What about the direction of revenue for Cores through Industry / Clinical partnerships? • Is it within our mission? • How to resolve potential conflicts? • Biobanks and “Personalized / Precision Medicine” • How should this be prioritized? • How does this effort support the new Division / Center of Bioinformatics and Personalized Medicine?